Grifols (GRFS) Interest Coverage Ratio (2010 - 2019)
Grifols' (GRFS) quarterly Interest Coverage Ratio came in at 1.5 in Q2 2018, down 136.5% YoY from 4.1 in Q2 2017, and down 110.73% on a QoQ basis from 13.96 in Q4 2017.
Grifols (GRFS) Interest Coverage Ratio (2010 - 2019) Analysis & Trends
Grifols (GRFS) has 9 years of Interest Coverage Ratio data on file, last reported at 1.5 in Q2 2018.
- Quarterly Interest Coverage Ratio fell 136.5% year-over-year to 1.5 in Q2 2018, while the trailing twelve-month figure through Mar 2020 was 8.565176496635736e+16 (down 9.908517777216024e+17% YoY) and the FY2025 annual result came in at 1.99, up 19.13% from the prior year.
- Interest Coverage Ratio declined to 1.5 in Q2 2018, from 13.96 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 7678693.54 in Q2 2014 to a low of 3.66 in Q1 2016.
- A 5-year average of 511915.68 and a median of 3.89 in 2015 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2014 — Interest Coverage Ratio surged 252037926.28% — and 2016, when it tumbled 194.11%.
- Tracing GRFS's Interest Coverage Ratio over 5 years: stood at 3.81 in 2014, then slumped by 178.38% to 2.99 in 2015, then soared by 135.23% to 1.05 in 2016, then surged by 1225.93% to 13.96 in 2017, then tumbled by 110.73% to 1.5 in 2018.
- The last three Interest Coverage Ratio figures came in at 1.5 (Q2 2018), 13.96 (Q4 2017), and 4.1 (Q2 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 10.28 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 7.27 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 5.22 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -42.08 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -2.64 |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -7.67 |
| Jun 30, 2018 | -1.50 |
| Dec 31, 2017 | 13.96 |
| Jun 30, 2017 | 4.10 |
| Dec 31, 2016 | 1.05 |
| Sep 30, 2016 | 3.91 |
| Jun 30, 2016 | 3.74 |
| Mar 31, 2016 | -3.66 |
| Dec 31, 2015 | -2.99 |
| Sep 30, 2015 | 4.09 |
| Jun 30, 2015 | 4.00 |
| Mar 31, 2015 | 3.89 |
| Dec 31, 2014 | 3.81 |
| Sep 30, 2014 | 3.98 |
| Jun 30, 2014 | 7.68 Mn |
| Mar 31, 2014 | 3.21 |
| Dec 31, 2013 | 2.84 |
| Sep 30, 2013 | 3.21 |
| Jun 30, 2013 | 3.05 |
| Mar 31, 2013 | 3.18 |